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Abstract
Background: Hereditary hemorrhagic telangiectasia is a rare autosomal dominant inherited disease characterized
by vascular dysplasia. To the best of our knowledge, we report the first case in the literature of definite hereditary
hemorrhagic telangiectasia diagnosed in western Kenya, a resource-limited setting with limited treatment options.
Case presentation: A 60-year-old black Kenyan woman was admitted 1 year ago to a hospital in western Kenya
with an 11-year history of recurrent spontaneous epistaxis. Her physical examination revealed that she had
telangiectasias on the tongue and hard palate, severe pallor, and hepatomegaly. A chest radiograph revealed right
middle lobe opacity. After a positive saline contrast echocardiography, she underwent contrast-enhanced chest
computed tomography, which revealed a large pulmonary arteriovenous malformation and multiple hepatic
arteriovenous malformations. Therefore, she fulfilled criteria for definite hereditary hemorrhagic telangiectasia. She
was managed with nasal packing, tranexamic acid, oral ferrous sulfate, and blood transfusions, as other treatment
options were unavailable in this setting.
Conclusions: This rare case of hereditary hemorrhagic telangiectasia demonstrates that it occurs in an African
population and that diagnostic challenges in resource-limited settings can be surmounted. Treatment options
remain limited in these settings.
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Background
Hereditary hemorrhagic telangiectasia (HHT) is a
rare disease worldwide. It is an autosomal dominant
inherited disease that causes vascular dysplasia mainly
affecting mucocutaneous and visceral organs. Only one
case of possible HHT has been described previously in
sub-Saharan Africa (SSA) [1]. Clinical presentations of
HHT are age-related and variable, with epistaxis being the
most common presenting symptom [2, 3]. Diagnosis and
management of HHT are challenging in areas with scarce
resources such as Kenya. This case report and literature
review highlights these challenges.
Case presentation
We present a case of a 60-year-old Kenyan woman who
was admitted 1 year ago to a hospital in western Kenya
with complaints of epistaxis and right-sided chest pain
for the preceding 3 days. She reported an 11-year history
of recurrent spontaneous epistaxis that had worsened 3
days before admission. Apart from one episode of post-
partum hemorrhage (PPH) in the past that had required
blood transfusion, she had no other history of bleeding
tendencies. Her right-sided chest pain was pricking in
nature and radiated to her upper back. She had associ-
ated shortness of breath but no cough or platypnea. She
also complained of severe headache that she described
as global, persistent, and not worsened by light but
associated with dizziness. She had never been on any
medications for the epistaxis.
She had two previous admissions: one 17 years ago for
PPH that required blood transfusion and another in
early childhood for malaria. She is a widow, mother of
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five children, and a first-born in a family of seven. Two
of her sisters had histories of mild recurrent epistaxis.
She had a history of occasional alcohol use but had
stopped 4 years before admission. She had no history of
tobacco use.
Her physical examination revealed a middle-aged
woman in fair general condition with severe pallor and a
tinge of jaundice. She had no cyanosis or lymphadenop-
athy. Her vital signs were blood pressure of 95/60 mmHg,
pulse rate of 100 beats/minute, respiratory rate of 22
breaths/minute, and axillary temperature of 37 °C. Her
oxygen saturation by pulse oximetry was 95 % on room
air, which dropped to 92 % 5 minutes after changing
positions from supine to upright.
Her oral examination revealed multiple, guttate-like,
erythematous blanching lesions with a tendency to co-
alesce on the edges of the tongue, as well as a few grouped
erythematous, well-demarcated, blanching lesions on the
hard palate (Fig. 1).
Her cardiovascular examination was notable for mild
tachycardia, a bounding pulse, and a hemic murmur.
She had hepatomegaly of 7 cm below the costal margin
with a liver span of 17 cm and a bruit on auscultation.
The rest of her systemic examination was unremarkable.
Her laboratory investigations revealed normal activated
partial thromboplastin time, prothrombin time, inter-
national normalized ratio, and bleeding time. Her
complete blood count showed hemoglobin of 4.1 g/dl,
mean corpuscular volume of 60.6 fl, a normal white blood
cell count, and slight thrombocytosis of 471 × 103/μl. Her
peripheral blood smear showed a decreased red blood cell
count with moderate microcytosis and marked hypochro-
masia, suggestive of iron deficiency anemia. She had
slightly elevated alkaline phosphatase and total bilirubin
levels. A chest radiograph demonstrated opacity in the
right midzone, and a transthoracic contrast echocardiog-
raphy (TTCE) with agitated saline confirmed the presence
of a right-to-left shunt (Additional file 1: Video 1). Consid-
ering either a large atrium-level or pulmonary shunt,
we then performed contrast-enhanced chest computed
tomography (CT), which revealed a large pulmonary
arteriovenous malformation (AVM) and multiple hepatic
AVMs (Fig. 2).
At presentation, we considered inherited coagulopa-
thies such as von Willebrand disease, given the histories
of her two siblings, chronic liver disease, and platelets
disorders as possible causes of epistaxis. These were
ruled out by normal coagulation studies and bleeding
time, however.
The diagnosis of HHT is based on the international
consensus diagnostic criteria (the Curacao diagnostic
criteria), which use clinical findings of epistaxis, muco-
cutaneous telangiectasias, visceral vascular malforma-
tion, and positive family history (Table 1) [4]. Our
patient was diagnosed with definite HHT, as she fulfilled
three criteria. Although she had reported that two her
siblings had histories of mild epistaxis, this criterion was
not considered in this case, as the siblings’ diagnoses
were not confirmed to be HHT.
Diagnosis of this rare disease is a challenge in resource-
limited settings due to its variability in presentation and
lack of clear diagnostic modalities. As shown in our pa-
tient, late diagnosis is due to many factors, including low
clinical suspicion among clinicians, difficulties in accessing
health care by the patient, and economic costs associated
with further imaging. The costs of these investigations
were waived for our patient.
The patient’s epistaxis was controlled by repeated
nasal packing. She also received 1 g of tranexamic acid
intramuscularly, which was continued orally at 500 mg
three times per day for 5 days. Her epistaxis stopped 5
days after admission. She also received a transfusion of 6
U of whole blood and was put on oral ferrous sulfate
325 mg three times daily. Her repeat complete blood
count showed hemoglobin of 12 g/dl 10 days after
admission. She was discharged to home on oral ferrous
Fig. 1 Telangiectasias on the tongue and hard palate. A photograph
of the patient’s oral cavity showing multiple, guttate-like, erythematous
lesions with a tendency to coalesce on the edges of the tongue, as
well as a few grouped erythematous, well-demarcated lesions on the
hard palate. The lesions were nontender and blanched upon pressure
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sulfate with follow-up in our clinic, as other clinical
management procedures were not available. One year
after her discharge, our patient was still experiencing
intermittent epistaxis and remained on iron therapy.
Discussion
Hereditary hemorrhagic telangiectasia (HHT), also called
Rendu-Osler-Weber syndrome, is a rare autosomal dom-
inant inherited systemic disease. It is characterized by
telangiectasias of the skin and mucous membranes as
well as large AVMs mainly in pulmonary, hepatic, and
cerebral circulation. Globally, the prevalence varies be-
tween 1 in 5,000 and 1 in 10,000 [5]. Notably, in SSA,
only one case of possible HHT, in a black African male
in Nairobi, Kenya, has been described [1].
Clinical manifestations of HHT vary with age, with
spontaneous recurrent epistaxis being the most common,
affecting 90 % of the patients by age 21 years [2, 3].
Our patient developed epistaxis at the age of 49 years,
which was later than would have been expected. Most
patients present with severe iron deficiency anemia re-
quiring blood transfusion and iron supplementation.
Although our patient was managed with repeated nasal
packing and tranexamic acid, in a resource-sufficient
setting she could have benefited from other options,
such as laser ablation, arterial ligation, septodermoplasty,
or systemic therapies [6–8].
The initial appearance of our patient’s oral telangiectatic
lesions is unknown, and she never reported any bleeding.
Telangiectasias are more common with increasing age,
rarely bleed, and affect 70 % of patients by age 30 years
[2]. Recurrent gastrointestinal (GI) bleeding occurs in up
to 30 % of patients as a result of telangiectasias [2]. Our
patient had no history of GI symptoms.
Visceral AVMs, which are predominantly asymptom-
atic, occur in the pulmonary (50 %), hepatic (30 %), cere-
bral (10 %), and, rarely, spinal vasculature (1 %) [5].
Pulmonary AVMs can rarely present with paradoxical
systemic embolization, leading to ischemic stroke or
brain abscess [9]. Our patient had both pulmonary and
hepatic AVMs. She was not screened for cerebral AVMs,
but there are reports in the literature of these AVMs as
being multiple and with a low risk of hemorrhage [10].
The headache described by our patient was unlikely to
have been migraine with aura, which has been reported to
occur in some patients [11]. Our patient had no clinical
signs of central nervous system disease on examination.
Chest pain and dyspnea in our patient were likely due
to hypoxemia resulting from a secondary pulmonary
shunt, compounded by severe anemia. During saline
TTCE, the microbubbles appeared during the fourth
beat in the left atrium, but there was poor visualization
of the shunt origin. CT scans confirmed the presence of
a large right pulmonary AVM with a feeding artery of
6.35 mm. The feeding artery met the criterion for trans-
catheter embolotherapy, which considers a ≥3 mm as a
threshold above which to warrant this procedure [12]. It
was not possible to carry out this intervention in the local
hospital; however, in accordance with the international
Fig. 2 Computed tomography of the chest demonstrating a large pulmonary arteriovenous malformation (a) and multiple hepatic arteriovenous
malformations (b). Contrast-enhanced computed tomographic scans show (a) a dilated vessel in the right midperipheral lung region creating a
pool of contrast, as well as a large draining vein into the right pulmonary vein suggestive of an arteriovenous malformation, and also show (b)
multiple intrahepatic tortuous vessels enhancing on arterial phase suggestive of intrahepatic arteriovenous malformations and peripheral smaller
ones with early venous phase displaying early filling of the hepatic veins. The splenic hilum also shows tortuous vessels suggestive of splenic hilar
arteriovenous malformations
Table 1 Diagnostic criteria for hereditary hemorrhagic
telangiectasia (Curacao criteria)
Criteria Characteristics
Epistaxis (nosebleeds) Spontaneous and recurrent epistaxis
Mucocutaneous
telangiectasias
Multiple telangiectasias at characteristic
sites (for example, lips, tongue, nose and
hands)
Arteriovenous malformations Involving visceral organs, including the
pulmonary, gastrointestinal, hepatic, and
cerebral vasculature
Family history of hereditary
hemorrhagic telangiectasia
A first-degree relative with hereditary
hemorrhagic telangiectasia
The hereditary hemorrhagic telangiectasia diagnosis is classified as definite if
three or four criteria are present; possible/suspected if two criteria are present;
and unlikely if fewer than two criteria are present [4]
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guidelines recommendations, the patient was advised on
the use of antibiotic prophylaxis before high-risk proce-
dures to prevent brain abscess [7].
Hepatic AVMs can lead to complications such as high-
output heart failure and portal hypertension-associated
complications, and this can be managed with medical
therapy. However, if this therapy fails, then invasive
treatment with embolization and liver transplant can be
used to eliminate the hepatic AVMs [13].
Conclusions
This rare case of a patient with HHT demonstrates that
it occurs in our SSA population and that diagnostic chal-
lenges in resource-limited settings can be surmounted.
However, treatment remains limited in these settings.
Additional file
Additional file 1: Video 1. Video recording of saline transthoracic
contrast echocardiography. A video recording of transthoracic contrast
echocardiography (TTCE) showing the presence of right-to-left shunt after
agitated saline was injected into a peripheral vein. The saline contrast appears
on the left side of the heart during the fourth cardiac cycle. (MOV 6475 kb)
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